Emergence of NDM-5-Producing Carbapenem-Resistant Klebsiella pneumoniae and SIM-Producing Hypervirulent Klebsiella pneumoniae Isolated from Aseptic Body Fluid in a Large Tertiary Hospital, 2017–2018: Genetic Traits of blaNDM-Like and blaSIM-Like Genes as Determined by NGS

References

• Walker KA, Miner TA, Palacios M, et al. A Klebsiella pneumoniae regulatory mutant has reduced capsule expression but retains hypermucoviscosity. mBio. 2019;10:2. doi:10.1128/mBio.00089-19
   Web of Science ®Google Scholar
• Lepuschitz S, Schill S, Stoeger A, et al. Whole genome sequencing reveals resemblance between ESBL-producing and carbapenem resistant Klebsiella pneumoniae isolates from Austrian rivers and clinical isolates from hospitals. Sci Total Environ. 2019;662:227–235. doi:10.1016/j.scitotenv.2019.01.17930690357
   PubMed Web of Science ®Google Scholar
• Xie S, Fu S, Li M, et al. Microbiological Characteristics of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates Collected from County Hospitals. Infect Drug Resist. 2020;13:1163–1169. doi:10.2147/IDR.S24814732368107
   PubMed Web of Science ®Google Scholar
• Chung H, Pham KA, Thanh D, et al. A high-resolution genomic analysis of multidrug-resistant hospital outbreaks of Klebsiella pneumoniae. EMBO Mol Med. 2015;7(3):227–239. doi:10.15252/emmm.20140476725712531
   PubMed Web of Science ®Google Scholar
• Heinz E, E H, Bartholdson Scott J, et al. Resistance mechanisms and population structure of highly drug resistant Klebsiella in Pakistan during the introduction of the carbapenemase NDM-1. Sci Rep. 2019;9(1):2392. doi:10.1038/s41598-019-38943-730787414
   PubMed Web of Science ®Google Scholar
• Paczosa MK. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629–661. doi:10.1128/MMBR.00078-1527307579
   PubMed Web of Science ®Google Scholar
• Zhu C, Liyanapathirana V, Li C, et al. Characterizing mobilized virulence factors and multidrug resistance genes in carbapenemase-producing Klebsiella pneumoniae in a Sri Lankan Hospital. Front Microbiol. 2018;9:2044.30233529
   PubMed Web of Science ®Google Scholar
• Qi Y, Wei Z, Ji S, et al. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66:307–312. doi:10.1093/jac/dkq43121131324
   PubMed Web of Science ®Google Scholar
• Wei Z-Q, Du -X-X, Yu Y-S, Shen P, Chen Y-G, Li L-J. Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51(2):763–765. doi:10.1128/AAC.01053-0617145797
   PubMed Web of Science ®Google Scholar
• Kong Z, Cai R, Cheng C, et al. First reported nosocomial outbreak of NDM-5-producing Klebsiella pneumoniae in a neonatal unit in China. Infect Drug Resist. 2019;12:3557–3566.31814744
   PubMed Web of Science ®Google Scholar
• Garcia-Fulgueiras V, Zapata Y, Papa-Ezdra R, et al. First characterization of K. pneumoniae ST11 clinical isolates harboring blaKPC-3 in Latin America. Revista Argentina de Microbiología. 2019. doi:10.1016/j.ram.2019.10.003
   Web of Science ®Google Scholar
• Liu Y, Wan LG, Deng Q, Cao XW, Yu Y, Xu QF. First description of NDM-1-, KPC-2-, VIM-2- and IMP-4-producing Klebsiella pneumoniae strains in a single Chinese teaching hospital. Epidemiol Infect. 2014;143(2):376–384. doi:10.1017/S095026881400099524762211
   PubMed Web of Science ®Google Scholar
• Wang Z, Li M, Shen X, et al. Outbreak of blaNDM-5-Harboring Klebsiella pneumoniae ST290 in a Tertiary Hospital in China. Microb Drug Resist. 2019;25(10):1443–1448. doi:10.1089/mdr.2019.004631334685
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang H, Sun H, Chen H, Xu Y, Chen M. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob Agents Chemother. 2010;54(1):573–577. doi:10.1128/AAC.01099-0919805565
   PubMed Web of Science ®Google Scholar
• Li H, Zhang J, Liu Y, et al. Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme. Diagn Microbiol Infect Dis. 2014;78(1):63–65. doi:10.1016/j.diagmicrobio.2013.10.00224211218
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy66030423057
   PubMed Web of Science ®Google Scholar
• Li J, Zhang H, Ning J, et al. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control. 2019;8:44. doi:10.1186/s13756-019-0489-330834112
   PubMed Web of Science ®Google Scholar
• Moura Q, Esposito F, Fernandes MR, et al. Genome sequence analysis of a hypermucoviscous/hypervirulent and MDR CTX-M-15/K19/ST29 Klebsiella pneumoniae isolated from human infection. Pathog Dis. 2017;75:9. doi:10.1093/femspd/ftx121
   Web of Science ®Google Scholar
• Liu Z, Gu Y, Li X, et al. Identification and characterization of NDM-1-producing Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae in China. Ann Lab Med. 2019;39(2):167. doi:10.3343/alm.2019.39.2.16730430779
   PubMed Web of Science ®Google Scholar
• CaLS I. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• FaDA s. TYGACIL® (tigecycline) for injection, for intravenous use. Initial US. 2016.
   Google Scholar
• I C. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• Hong M-Y, Hsieh -C-C, Yang C-Y, et al. A simple scoring algorithm that predicts abscesses in adults with community-onset Klebsiella pneumoniae bacteremia: hypermucoviscosity matters. Infect Drug Resist. 2020;13:1045–1055. doi:10.2147/IDR.S24080932341657
   PubMed Web of Science ®Google Scholar
• Liu Y, Du F-L, Xiang T-X, et al. High prevalence of plasmid-mediated quinolone resistance determinants among serotype K1 hypervirulent Klebsiella pneumoniae isolates in China. Microbial Drug Resist. 2019;25(5):681–689. doi:10.1089/mdr.2018.0173
   PubMed Web of Science ®Google Scholar
• Yu F, Lv J, Niu S, et al. Multiplex PCR analysis for rapid detection of Klebsiella pneumoniae carbapenem-resistant (sequence type 258 [ST258] and ST11) and hypervirulent (ST23, ST65, ST86, and ST375) strains. J Clin Microbiol. 2018;56:9. doi:10.1128/JCM.00731-18
   Web of Science ®Google Scholar
• Brisse S, P V, Haugaard AB, et al. wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol. 2013;51(12):4073–4078. doi:10.1128/JCM.01924-1324088853
   PubMed Web of Science ®Google Scholar
• Fu Y, Xu M, Liu Y, Li A, Zhou J. Virulence and genomic features of a blaCTX-M-3 > and blaCTX-M-14 coharboring hypermucoviscous Klebsiella pneumoniae of serotype K2 and ST65. Infect Drug Resist. 2019;12:145–159. doi:10.2147/IDR.S18728930655681
   PubMed Web of Science ®Google Scholar
• Morici P, W F, Rizzato C, et al. Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains. Eur J Clin Microbiol Infect Dis. 2017;36(10):1739–1748. doi:10.1007/s10096-017-2987-728470337
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-131478103
   PubMed Web of Science ®Google Scholar
• Chang H, W J, Zhou W, et al. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014–2018: clinical impact of carbapenem resistance in a large tertiary hospital of China. J Infect Public Health. 2020;13:784–790.31843651
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Q, Liu W-E, Yan Q. Risk factors for subsequential carbapenem-resistant Klebsiella pneumoniae clinical infection among rectal carriers with carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist. 2020;13:1299–1305. doi:10.2147/IDR.S24710132440167
   PubMed Web of Science ®Google Scholar
• Pan F, Tian D, Wang B, et al. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai. BMC Infect Dis. 2019;19(1):678. doi:10.1186/s12879-019-4298-331370804
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang S, Fang R, et al. Dynamic epidemiology and virulence characteristics of carbapenem-resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016. Infect Drug Resist. 2020;13:931–940. doi:10.2147/IDR.S24303232280249
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):252–275. doi:10.1093/femsre/fux01328521338
   PubMed Web of Science ®Google Scholar
• Muhammad U, Qamar TRW, Toleman MA, et al. Dissemination of genetically diverse NDM-1, −5, −7 producing-Gram-negative pathogens isolated from pediatric patients in Pakistan. Future Microbiol. 2019;14:691–704. doi:10.2217/fmb-2019-001231148474
   PubMed Web of Science ®Google Scholar
• Alizadeh N, Ahangarzadeh Rezaee M, Samadi Kafil H, et al. Evaluation of resistance mechanisms in carbapenem-resistant Enterobacteriaceae. Infect Drug Resist. 2020;13:1377–1385. doi:10.2147/IDR.S24435732494169
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Bhattacharjee A, Naha S, et al. Molecular characterization of NDM-1-producing Klebsiella pneumoniae ST29, ST347, ST1224, and ST2558 causing sepsis in neonates in a tertiary care hospital of North-East India. Infect Genetics Evol. 2019;69:166–175. doi:10.1016/j.meegid.2019.01.02430677535
   PubMed Web of Science ®Google Scholar
• Higashino M, Murata M, Morinaga Y, et al. Fluoroquinolone resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Japanese tertiary hospital: silent shifting to CTX-M-15-producing K. pneumoniae. J Med Microbiol. 2017;66(10):1476–1482. doi:10.1099/jmm.0.00057728893357
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jin L, Ouyang P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75(2):327–336. doi:10.1093/jac/dkz44631713615
   PubMed Web of Science ®Google Scholar
• Huang Y-H, Chou S-H, Liang S-W, et al. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan. J Antimicrob Chemother. 2018;73(8):2039–2046. doi:10.1093/jac/dky16429800340
   PubMed Web of Science ®Google Scholar
• De Campos TA, Gonçalves LF, Magalhaes KG, et al. A fatal bacteremia caused by hypermucousviscous KPC-2 producing extensively drug-resistant K64-ST11 Klebsiella pneumoniae in Brazil. Front Med (Lausanne). 2018;5:265. doi:10.3389/fmed.2018.0026530298131
   PubMed Web of Science ®Google Scholar
• Lu Y, Feng Y, McNally A, Zong Z. Occurrence of colistin-resistant hypervirulent Klebsiella variicola. J Antimicrob Chemother. 2018;73(11):3001–3004. doi:10.1093/jac/dky30130060219
   PubMed Web of Science ®Google Scholar
• Roe CC, Vazquez AJ, Esposito EP, Zarrilli R, Sahl JW. Diversity, virulence, and antimicrobial resistance in isolates from the newly emerging Klebsiella pneumoniae ST101 lineage. Front Microbiol. 2019;10:542.31001209
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu L, Fu Y, et al. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro. Ann Palliat Med. 2019;8(5):622–631. doi:10.21037/apm.2019.09.1131735038
   PubMed Web of Science ®Google Scholar